OncoMed Pharmaceuticals Inc (NASDAQ:OMED)

27.67
Delayed Data
As of Mar 05
 +0.93 / +3.48%
Today’s Change
16.57
Today|||52-Week Range
39.50
+27.16%
Year-to-Date
No recent news for OncoMed Pharmaceuticals Inc.

Today’s Trading

Previous close26.74
Today’s open26.94
Day’s range-- - --
Volume186,217
Average volume (3 months)170,505
Market cap$825.5M
Dividend yield--
Data as of 03/05/2015

Growth & Valuation

Earnings growth (last year)-93.00%
Earnings growth (this year)+30.44%
Earnings growth (next 5 years)--
Revenue growth (last year)+53.07%
P/E ratioNM
Price/Sales10.57
Price/Book6.66

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.24+2.85%
EPZMEpizyme Inc+0.40+1.67%
INFIInfinity Pharmaceuti...+0.34+2.10%
RGENRepligen Corp+0.67+2.67%
Data as of 03/05/2015

Financials

Next reporting dateMarch 13, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$37.8M
Annual profit (last year)-$26.1M
Net profit margin-69.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul J. Hastings
CFO, SVP-Corporate Development &
Finance
Sunil Patel
Corporate headquarters
Redwood City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account